NRP/571 Week 6: Orthopedic Procedure Case, sample paper

Reviewed by Lenora Whitcombe, MSN, RN · University of Phoenix

This page holds a complete NRP/571 Week 6 sample paper on an orthopedic procedure, in true APA form. A 64-year-old with knee osteoarthritis wants an injection before a two-week trip. A family nurse practitioner student applies the ACR/Arthritis Foundation guideline, weighs a Cochrane review and a randomized trial of repeated injections, performs a sterile injection with landmark technique and sets limits on repeat use.

1

One Injection Before the Trip, Not Four a Year: A Corticosteroid Knee Injection for Osteoarthritis in a 64-Year-Old, Weighed Against a Two-Year Trial of Repeated Injections

[Student Name]

University of Phoenix

NRP/571: Advanced Health Assessment II and Clinical Procedures

Week 6 Assignment

[Instructor Name]

[Date]

The patient is a composite written for a model paper.

What this part is doingThe title sets the patient's specific goal against the evidence on repeated use. The reader expects the procedure matched to the goal.
2

Mrs. L., a 64-year-old retired teacher, has osteoarthritis of the left knee confirmed on radiographs. Despite weight loss of 5 kg, physical therapy exercises and topical diclofenac, she has pain climbing stairs and walking long distances. In three weeks she leaves on a two-week walking tour, and she asks for "a shot to get me through." She has no diabetes. This paper describes the decision and procedure.

The Guideline

The 2019 ACR/Arthritis Foundation guideline strongly recommends exercise, weight loss for those with overweight and self-management programs, and strongly recommends intra-articular glucocorticoid injections for knee osteoarthritis, while conditionally recommending topical nonsteroidal anti-inflammatory drugs and other measures (Kolasinski et al., 2020). Mrs. L. has already used core treatments, and an injection is a guideline-supported option.

The Evidence on Benefit

A Cochrane review of intra-articular corticosteroids for knee osteoarthritis concluded that whether there are clinically important benefits after one to six weeks remains unclear, because of low-quality evidence, heterogeneity and small-study effects, and that the single trial with adequate protection against bias found no benefit (Jüni et al., 2015). The evidence suggests that some patients benefit for a few weeks, but the average effect may be smaller than often assumed.

The Evidence on Repeated Injections

McAlindon et al. (2017) randomly assigned 140 patients with symptomatic knee osteoarthritis to injections of triamcinolone or saline every three months for two years. Triamcinolone produced significantly greater loss of cartilage thickness, a mean of 0.21 mm compared with 0.10 mm, and no significant difference in knee pain. The authors concluded that the findings did not support this treatment for patients with symptomatic knee osteoarthritis.

A single injection timed to a goal is a different decision from an injection every three months as a way of life.

What this part is doingThe guideline recommendation, the uncertain short-term evidence and the harm from repeated use are all presented before the decision.
3

The Decision

Mrs. L.'s goal is specific and time-limited. A single injection may help her through the trip, with a small risk, and the trial's harm came from repeated injections over two years. We agree to one injection now, with the understanding that it may or may not help, and that we will not repeat injections routinely.

Why Not Hyaluronic Acid or Platelet-Rich Plasma

Mrs. L. asked about other injections she had read about. The ACR/Arthritis Foundation guideline conditionally recommends against hyaluronic acid injections for knee osteoarthritis and strongly recommends against platelet-rich plasma and stem cell injections, citing lack of convincing benefit (Kolasinski et al., 2020). I explain this so her choice is informed and she does not pay for treatments the evidence does not support.

Timing Before the Trip

Injecting three weeks before travel allows time for benefit to appear and for any post-injection flare to settle before she leaves. Injecting the day before would leave no margin for a flare.

Ultrasound Guidance

Ultrasound guidance can improve needle placement accuracy, especially in obese knees or when fluid is present. For a nonobese knee without effusion, the landmark technique is commonly used in primary care. If an effusion were present, aspirating it first would both improve accuracy and provide fluid for analysis.

Consent

I explain the benefits, the uncertainty of benefit, the risks, including infection, a post-injection pain flare, skin changes and temporary glucose rise, and alternatives. She consents.

The Procedure

With Mrs. L. seated and the knee flexed to 90 degrees, I identify the anteromedial approach landmarks: the soft spot medial to the patellar tendon, just below the patella. After marking the site, I clean it with chlorhexidine and use sterile technique without touching the prepared skin. I inject 40 mg of triamcinolone acetonide mixed with 3 mL of 1% lidocaine using a 25-gauge needle directed toward the intercondylar notch, aspirating first to ensure the needle is not in a vessel. The injection flows without resistance. I apply a bandage.

Aftercare

She should rest the knee for 24 hours, avoid strenuous activity for two days and use ice if a flare occurs. She should call for increasing redness, warmth, swelling or fever, which could indicate infection. Benefit, if it occurs, usually begins within several days.

Planning Beyond the Trip

After she returns, we will review her function and plan for the long term: continued strengthening, weight management and walking aids for long distances. If pain becomes disabling despite these, referral for evaluation of knee replacement is appropriate, rather than a pattern of repeated injections.

Glucose and Other Systemic Effects

Although Mrs. L. does not have diabetes, corticosteroid injections can transiently raise blood glucose and, rarely, cause facial flushing or sleep disturbance for a few days. I mention these so she is not alarmed.

What Counts as Success

We agree to judge the injection by whether she can complete the daily walks on her trip with manageable pain. If it does not help, that information is also useful: it argues against future injections and toward other options.

Nonpharmacologic Support for the Trip

Walking poles reduce load on the knee on hills, and planning rest breaks and cushioned footwear help. I suggest she continue her quadriceps strengthening exercises before and during the trip, since strength supports the joint regardless of the injection's effect.

Pain Relief Options While Away

She can continue topical diclofenac and use acetaminophen as needed. I avoid prescribing oral anti-inflammatory drugs for daily use during travel because of stomach and kidney risks, especially with dehydration.

Why Aspiration Before Injection

Drawing back on the syringe before injecting confirms the needle is not in a blood vessel. If synovial fluid returns, it confirms intra-articular placement; if the fluid were cloudy, the injection would be stopped and the fluid sent for analysis to rule out infection or crystals.

Skin Changes

Triamcinolone can cause thinning or lightening of the skin at the site, more noticeable in darker skin, if it leaks into superficial tissue. Careful depth and a small bandage reduce this risk.

Documenting the Limit

I write in the plan that injections will be limited to no more than a few per year and will not be scheduled routinely, so that the reasoning from the two-year trial carries into future visits with other clinicians (McAlindon et al., 2017).

Her Questions

She asked whether the injection would "fix" the arthritis. I explained that it may reduce pain for a time but does not repair cartilage, and that exercise and weight control remain the foundation.

Documentation

The note records the indication, consent, site and approach, skin preparation, needle, medication and dose, aspiration, the patient's tolerance and the aftercare instructions.

Conclusion

Mrs. L.'s knee osteoarthritis persisted despite core treatments, and a guideline-supported corticosteroid injection was chosen for a specific, time-limited goal. Evidence shows uncertain short-term benefit and, from a two-year trial, more cartilage loss with no pain benefit from repeated injections. A single, sterile, landmark-guided injection with clear limits on repetition matches the procedure to her goal and the evidence.

What this part is doingThe conclusion joins the evidence, the decision and the limits. Every source cited in the paper appears in the reference list.
4

References

Jüni, P., Hari, R., Rutjes, A. W. S., Fischer, R., Silletta, M. G., Reichenbach, S., & da Costa, B. R. (2015). Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database of Systematic Reviews, 2015(10), Article CD005328. https://doi.org/10.1002/14651858.CD005328.pub3

Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., Gellar, K., Harvey, W. F., Hawker, G., Herzig, E., Kwoh, C. K., Nelson, A. E., Samuels, J., Scanzello, C., White, D., . . . Reston, J. (2020). 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis & Rheumatology, 72(2), 220-233. https://doi.org/10.1002/art.41142

McAlindon, T. E., LaValley, M. P., Harvey, W. F., Price, L. L., Driban, J. B., Zhang, M., & Ward, R. J. (2017). Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: A randomized clinical trial. JAMA, 317(19), 1967-1975. https://doi.org/10.1001/jama.2017.5283

How this NRP 571 Week 6 example is structured

The NRP/571 Week 6 work usually addresses orthopedic procedures such as splinting and joint injection. This paper covers the indication and the evidence first, then the technique and aftercare, and ends with a plan that uses the procedure well rather than often. Students search this week as NRP 571 Week 6, NRP571 Wk 6 or NRP/571 Wk 6; all three are the same assignment.

NRP/571 Week 6 questions, answered

What does NRP/571 Week 6 usually ask for?

Many sections ask students to describe the indication, evidence, technique and aftercare for an orthopedic procedure such as a joint injection or splinting.

Do corticosteroid injections help knee osteoarthritis?

They can provide short-term pain relief, and guidelines recommend them, but the size and duration of benefit are uncertain, and a two-year trial of repeated injections found more cartilage loss with no pain benefit.

What are the risks of a knee injection?

Infection, which is rare, a temporary flare of pain, skin thinning or lightening at the site and temporary rise in blood glucose in people with diabetes.

Write yours, or have the desk draft it

This paper is an original model document written by our desk, not a submitted student paper and not an official University of Phoenix document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.